🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the safety and efficacy of pembrol...
Status
Completed
Location
St Joseph Heritage Healthcare-Oncology ( Site 0004)
Start Date
2021-10-07
Trial ID
NCT05008224
This pilot study uses \[18F\]F AraG PET imaging to evaluate the immunologic...
Status
Recruiting
Location
University of Iowa Hospitals and Clinics
Start Date
2023-11-01
Trial ID
NCT06107374
Treatments Being Tested
To evaluate the potential usefulness of 68Ga-NK224 positron emission tomogr...
Status
Recruiting
Location
The First Affiliated Hospital of Xiamen University
Start Date
2023-05-30
Trial ID
NCT06754345
This study aims to determine the feasibility of non-invasive quantitative P...
Status
Terminated
Location
Yale University PET Center
Start Date
2023-02-21
Trial ID
NCT05408871
Treatments Being Tested
To utilize the \[68Ga\]Ga-THP-PDL1-3 molecular probe to non-invasively dete...
Status
Recruiting
Location
Beijing Cancer Hospital
Start Date
2024-04-01
Trial ID
NCT06383598
Treatments Being Tested
The aim of this study was to establish and optimize the imaging method of \...
Status
Unknown
Location
Huashan Hospital
Start Date
2023-03-12
Trial ID
NCT06165874
Treatments Being Tested
This phase I trial tests the safety, side effects, best dose, and effective...
Status
Recruiting
Location
City of Hope Comprehensive Cancer Center
Start Date
2025-05-05
Trial ID
NCT06439836
This phase II trial tests the addition of chemotherapy, with carboplatin an...
Status
Recruiting
Location
Banner University Medical Center - Tucson
Start Date
2026-04-24
Trial ID
NCT07195734
This is a prospective, single center, single-arm clinical trial in 20 patie...
Status
Terminated
Location
Johns Hopkins University
Start Date
2021-02-01
Trial ID
NCT04524195
Treatments Being Tested
Non-invasive imaging of tumor PD-L1 expression with 89Zr-labeled durvalumab...
Status
Completed
Location
Amsterdam UMC
Start Date
2019-04-15
Trial ID
NCT03829007
Treatments Being Tested